↓ Skip to main content

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early…

Overview of attention for article published in Radiation Oncology, August 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
facebook
1 Facebook page

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
79 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments
Published in
Radiation Oncology, August 2012
DOI 10.1186/1748-717x-7-145
Pubmed ID
Authors

Marta Scorsetti, Filippo Alongi, Antonella Fogliata, Sara Pentimalli, Pierina Navarria, Francesca Lobefalo, Carlos Garcia-Etienne, Alessandro Clivio, Luca Cozzi, Pietro Mancosu, Giorgia Nicolini, Eugenio Vanetti, Marco Eboli, Carlo Rossetti, Arianna Rubino, Andrea Sagona, Stefano Arcangeli, Wolfgang Gatzemeier, Giovanna Masci, Rosalba Torrisi, Alberto Testori, Marco Alloisio, Armando Santoro, Corrado Tinterri

Abstract

To report results in terms of feasibility and early toxicity of hypofractionated simultaneous integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant treatment after breast-conserving surgery.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 79 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 23%
Other 12 15%
Student > Master 11 14%
Student > Bachelor 5 6%
Student > Doctoral Student 4 5%
Other 15 19%
Unknown 14 18%
Readers by discipline Count As %
Medicine and Dentistry 38 48%
Physics and Astronomy 8 10%
Nursing and Health Professions 5 6%
Psychology 2 3%
Agricultural and Biological Sciences 2 3%
Other 7 9%
Unknown 17 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2012.
All research outputs
#17,664,478
of 22,675,759 outputs
Outputs from Radiation Oncology
#1,270
of 2,044 outputs
Outputs of similar age
#125,664
of 170,196 outputs
Outputs of similar age from Radiation Oncology
#19
of 31 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,044 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,196 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.